{"url_path":"/sec/bcda/8-k/2026-05-21/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **   **Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/925741/0001437749-26-017994-index.html","accession_number":"0001437749-26-017994","cik":"0000925741","ticker":"BCDA","issuer_name":"BioCardia, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/925741/0001437749-26-017994-index.html","primary_entity_key":"0000925741","primary_entity_name":"BioCardia, Inc."},"word_count":81,"has_tables":true,"body_markdown":"**Item 9.01**   **Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit No.**\n\n \n\n**Description**\n\n[99.1](ex_966329.htm)\n\n \n\n[BioCardia, Inc. press release dated May 21, 2026](ex_966329.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**BIOCARDIA, INC.**\n\n \n\n \n \n\n/s/ Peter Altman, Ph.D.\n\n \n\nPeter Altman, Ph.D.\n\n \n\nPresident and Chief Executive Officer\n\n \n\n \n \n\nDate: May 21, 2026"}